Jing W. Ke
20 Xisi Road
Nantong, 226001, China
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications
CytoAL: Towards Label-Efficient Cytology Diagnosis via Cellularity-Guided Active Learning.
Journal: IEEE transactions on image processing : a publication of the IEEE Signal Processing Society
Published: August 11, 2026
Novel phenotypic clusters of adult-onset diabetic kidney disease based on static and dynamic clustering algorithms - a data-driven multi-center study.
Journal: BMC endocrine disorders
Published: May 28, 2026
Correction: The ANGPTL3-integrin α5 axis drives retinal vascular leakage in diabetic retinopathy.
Journal: Journal of translational medicine
Published: May 09, 2026
Hollow micro-/nanostructures for enhanced pathogen theranostics.
Journal: Chemical Society reviews
Published: April 29, 2026
Reduction of PDZK1 promotes diabetic kidney disease by modulating fatty acid uptake in proximal tubular epithelial cells.
Journal: Metabolism: clinical and experimental
Published: February 24, 2026
Decoupling Parasitic Reactions From Bravais Law-Guided Electroredox Toward Highly Reversible (101)-Textured Zn Anodes for Ah-Scale Batteries.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: February 13, 2026
The association between AST/ALT (De Ritis) ratio and osteoporosis or bone mineral density in middle-aged and older adults: A cross-sectional analysis of NHANES data.
Journal: Medicine
Published: January 06, 2026
Activation of the NR3C1-STAT3-SLC6A2 signaling axis by a cyanidin-3-O-glucoside-enriched anthocyanin preparation attenuates neuroinflammation and pain hypersensitivity in intervertebral disc degeneration.
Journal: Journal of neuroinflammation
Published: December 01, 2025
A content-aware variable-rate framework for pathology learned image compression (PathoLIC).
Journal: Medical image analysis
Published: November 04, 2025
The ANGPTL3-integrin α5 axis drives retinal vascular leakage in diabetic retinopathy.
Journal: Journal of translational medicine
Published: October 29, 2025
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 15, 2025
Last Updated: 09/26/2026